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Weakening the Spindle Assembly Checkpoint by reduced expression of its components induces chromosome instability and aneuploidy
that are hallmarks of cancer cells. The tumor suppressor p14ARF is overexpressed in response to oncogenic stimuli to stabilize p53 halting
cell progression. Previously, we found that lack or reduced expression of p14ARF is involved in themaintenance of aneuploid cells in primary
human cells, suggesting that it could be part of a pathway controlling their proliferation. To investigate this aspect further, p14ARF was
ectopically expressed in HCT116 cells after depletion of the Spindle Assembly Checkpoint MAD2 protein that was used as a trigger for
aneuploidy. p14ARF Re-expression reduced the number of aneuploid cells in MAD2 post-transcriptionally silenced cells. Also aberrant
mitoses, frequently displayed in MAD2-depleted cells, were decreased when p14ARF was expressed at the same time. In addition, p14ARF
ectopic expression in MAD2-depleted cells induced apoptosis associated with increased p53 protein levels. Conversely, p14ARF ectopic
expression did not induce apoptosis in HCT116 p53KO cells. Collectively, our results suggest that the tumor suppressor p14ARF may have
an important role in counteracting proliferation of aneuploid cells by activating p53-dependent apoptosis.
J. Cell. Physiol. 231: 336–344, 2016. © 2015 Wiley Periodicals, Inc.
The main function of mitosis is to ensure the ﬁdelity of the
segregation of one copy of each chromosome into daughter
cells. The Spindle Assembly Checkpoint (SAC) is a surveillance
system working in mitosis that ensures chromosomal stability
by preventing anaphase onset until all sister chromatids are
properly attached to the mitotic spindle (amphitelic
attachment). The SAC is regulated by the Mitotic Checkpoint
Complex (MCC), whose formation is induced by one or more
unattached kinetochores. The MCC binds and inhibits the
Anaphase-Promoting Complex/Cyclosome (APC/C) avoiding
chromosome mis-segregation (Silva et al., 2011). Defective
mitoses, caused by weakening the SAC, could promote
aneuploidy characterized by numerical and structural changes
of chromosomes that contribute to genomic instability, typical
of many human tumors (Weaver and Cleveland, 2009;
Thompson and Compton, 2011). However, it is not yet clearly
established if aneuploidy is a cause of tumor initiation. The
vision that aneuploidy is linked to tumorigenesis may be
doubted by data showing that mutations of SAC components
are lethal early in the embryonic development of mice (Holland
and Cleveland, 2009). Moreover, some results suggested that
aneuploidy can even have tumour suppressive effects at least
under certain conditions (Weaver and Cleveland, 2007; Sussan
et al., 2008).
Nevertheless, a weakened or aberrant SAC can promote
cancer, and one example is congenital Chromosomal Instability
(CIN) caused by the mutation of the SAC component BubR1,
that generates the Mosaic Variegated Aneuploidy (MVA)
disease associated with early cancer development (Hanks et al.,
2004). In addition, human tumor cells HCT116 and Murine
Embryonic Fibroblasts (MEFs) haploinsufﬁcient for MAD2
exhibit the aneuploid phenotype that could promote cancer
development (Michel et al., 2001), as well as mice that are
heterozygous for Centromere Protein E (CENPE) exhibit
whole chromosome aneuploidy associated with the increase of
spontaneous tumors (Weaver and Cleveland, 2007).
Although aneuploidy could potentially increase the risk of
neoplastic transformation, this seems to occur when it is
associated with mutations in tumor suppressor genes.
Consistent with this hypothesis, aneuploidy caused by MAD2
haploinsufﬁciency has been shown to increase both the
frequency and number of tumors in a p53 background
(Holland and Cleveland, 2009). Additionally, it was shown that
aneuploidy in near diploid HCT116 cells is associated with
activation of the p38-p53-p21waf1 axis (Thompson and
Compton, 2010). A p53-controlled pathway could also play an
important role in contrast to aneuploidy, resulting from various
cellular insults like an altered spindle checkpoint, thus
preserving chromosomal stability.
Previously, we showed that aneuploidy caused by MAD2
haploinsufﬁciency activated a p53-dependent senescence
pathway in IMR90 human ﬁbroblasts to counteract aneuploidy
deleterious effects (Lentini et al., 2012). On the contrary,
aneuploidy promoted by MAD2 post-transcriptional silencing
appeared to be well tolerated in MCF10A epithelial cells where
the ARF gene coding for p14ARF is deleted (Lentini et al., 2012).
In addition, we showed that primary human ﬁbroblasts (IMR90)
perceived DNMT1 absence, that would result in DNA
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hypomethylation, as a stress signal that activated a p14ARF/p53
pathway inducing G1 arrest. When this pathway was not
working, cells progressed incorrectly in the cell cycle with
altered DNA methylation (hypomethylation) that affected
chromosomal segregation thus resulting in aneuploidy (Barra
et al., 2012). These results suggest a potential role of p14ARF in
promotion and/or maintenance of the tolerance to aneuploidy.
To further investigate the putative role of p14ARF dysfunction in
aneuploid tolerance, we used as a system model near diploid
HCT116 cells in which p14ARF is not functional because of
promoter hypermethylation and gene mutation (Burri et al.,
2001). We expressed ectopically the ARF gene in these cells
where depletion of MAD2 by RNAi triggered aneuploidy. Here,
we show that p14ARF ectopic expression induced
p53-dependent apoptosis of aneuploid cells caused by MAD2
post-transcriptional silencing. Collectively, our results suggest a
new role for p14ARF to control proliferation of aneuploid cells.
Material And Methods
Cells and cell culture
Colon cancer cells HCT116 with MIN phenotype (near-diploid
cells) and p53/ HCT 116 cells (kindly provided by Dr. B.
Vogelstein, John Hopkins University, Baltimore, MD) were
cultured in D-MEM with 10% FBS (GIBCO, Invitrogen, Monza,
Italy), 100U/ml penicillin and 0.1mg/ml streptomycin. Cells were
cultured in a humidiﬁed atmosphere of 4% CO2 in air at 37° C.
Cell viability
To assess cell viability HCT116 cells were transfected with the
speciﬁc siRNA (siMAD2 and siMAD2 scramble) and the
plasmids pcDNA3.1 (empty) and pcDNA3.1-p14 for 72 h,
harvested by trypsinization and collected in a tube with 4ml of
phosphate buffered saline (PBS). Cell suspension (100ml) were
mixed with 100ml of Trypan Blue (Sigma–Aldrich, Milan, Italy)
and 10ml were placed in a Burker chamber for cell counting.
Cell transfection
Twenty-four hours after plating, cells were transfected with
MAD2 siRNA n°1 (50-AUACGGACUCACCUUUTT-30),
MAD2 siRNA n°2 (50 – AAGUGGUGAGGUCCUGGAATT –
30) or with control MAD2 scramble siRNA (50-
CAGUCGCGUUUGCGACUGG- 30) at a ﬁnal concentration
of 60 nM. After additionally ﬁve hours these cells were
transfected with the pcDNA3.1 empty plasmid or harbouring
the p14ARF c-DNA (kindly provided by S. Gazzeri, University J.
Fourier, La Tronche, France). The day of transfection the
siRNA or the plasmid DNA and the transfection reagent
(Lipofectamine 2000, Invitrogen, Monza, Italy) were diluted
separately in Opti-MEM (Invitrogen, Monza, Italy) mixed gently
and then incubated for 5min at room temperature. After
incubation the siRNA and the plasmid DNAwere mixed gently
with Lipofectamine 2000 (Invitrogen, Monza, Italy), allowed to
sit 30min at room temperature to allow complex formation,
and added to the plates with 2ml of Medium for 72 h.
Real time qRT-PCR
Primers to be used in Real-Time qRT-PCR experiments were
designed with Primer Express software (Applied Biosystems,
Monza, Italy) choosing amplicons of 70–100 bp. The selected
sequences were tested against public databases (BLAST) to
conﬁrm the identity of the genes. Total RNA was extracted
from cells by using the RNAeasy Mini kit according to the
manufacturer’s instruction (Qiagen, Milan, Italy). RNA was
reverse-transcribed in a ﬁnal volume of 40ml using the High
Capacity c-DNAArchive kit (Applied Biosystems) for 10min at
25°C and 2 h at 37°C. Real-Time qRT-PCR reaction was
performed as previously described (Barra et al., 2012).
Real-Time qRT-PCR was done in a ﬁnal volume of 20ml
comprising 1Master Mix SYBR Green (Applied Biosystems)




Protein concentration was measured using the Bio-RadProtein
Assay (Bio-Rad, Milan, Italy). Proteins (50mg) were separated by
10% SDS-PAGE containing 0.1% SDS and transferred to
Hybond-C nitrocellulose membranes (Amersham Life Science,
LittleChalfont, England) by electroblotting. Themembraneswere
sequentially incubated with primary antibodies against p53
(mouse, ab1101 Abcam, Cambridge, UK), p21waf1 (mouse,
ab18209 Abcam, Cambridge, UK), MAD2 (goat, C19-Santa Cruz,
Heidelberg, Germany), p14ARF (goat, C18-Santa Cruz,
Heidelberg, Germany) and HRP-conjugated mouse (ab6789,
Abcam, Cambridge, UK), or goat (ab97110, Abcam, Cambridge,
UK) as secondary antibodies. The target protein was detected
with enhanced chemiluminescence Western blotting detection
reagents (Pierce, Milan, Italy). Membranes were stained by
Ponceau-Red to conﬁrm equivalent loading of total protein in all
lanes.We used antibody against b-tubulin (mouse, SIGMA, Milan,
Italy, 1:10,000) to conﬁrm proteins loading. TheWB bands were
quantiﬁed with “ImageLab” software (Bio-Rad, Milan, Italy).
Determination of ploidy
Cells were treated with 0.2mg/ml colcemid (Demecolcine,
Sigma–Aldrich, Milan, Italy) for 4 h. Cells were harvested by
trypsinization, swollen in 75mM KCl at 37°C, ﬁxed with 3:1
methanol/acetic acid (v/v), and dropped onto clean, ice-cold
glass microscope slides. The slides were air dried and stained
with 3% GIEMSA a in phosphate-buffered saline for 10min.
Chromosome numbers were evaluated by looking at 50
metaphases for each sample using a Zeiss Axioskopmicroscope
under a 63objective. Theexperimentwas repeated twice. The
statistical analysis was done by using the Student’s t Test.
Immunoﬂuorescence microscopy
To visualize b-tubulin cells were grown on rounded glass
coverslips and then ﬁxed with Ethanol/Acetic acid 95:5 for
10min, permeabilized with 0.1% TritonX (Sigma–Aldrich,
Milan, Italy) in PBS for 15min and blocked with 0.1% Bovine
Serum Albumin (BSA) for 30min, both at room temperature.
Coverslips were incubated with a mouse monoclonal antibody
against b-tubulin mouse (1:200, Sigma–Aldrich, Milan, Italy)
over-night at 4° C, followed by a goat anti-mouse IgG-FITC
secondary antibody (Sigma–Aldrich, Milan, Italy, diluted 1:100
in PBS) for 1 h at 37° C. Nuclei were visualized with 1mg/ml of
40,6-Diamidino-2-phenylindole (DAPI) and examined on a
Zeiss Axioskop microscope equipped for ﬂuorescence, images
were captured with a CCD digital camera (AxioCam, Zeiss,
Milan, Italy) and then transferred to Adobe PhotoShop for
printing. We evaluated at least 100 mitoses for each sample.
The experiment was repeated twice.
Senescence-associated b-galactosidase activity assay
Senescence-Associated bGalactosidase (SA-bGal) activity was
measured 72 h after siMAD2 RNA transfection, cells were
washed in PBS, ﬁxed for 3min (room temperature) in 2%
paraformaldehyde, washed, and incubated for 24 h at 37°C (no
CO2) with fresh SA-bGal stain solution: 1mg/ml
5-bromo-4-chloro-3-indyl-D-galactopylanoside (X-Gal, SIGMA),
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5mmol/L potassium ferrocyanide, 5mmol/L potassium
ferricyanide,150mmol/L NaCl, 2mmol/L MgCl2, 0.01% sodium
deoxycholate, and 0.02% Nonidet-40 (Lentini et al., 2012).
Senescent cells were evaluated using a Zeiss Axioskop
microscope under a 20 objective (100 cells/sample). The
experiment was repeated twice.
Acridine orange/ethidium bromide assay
Acridine orange (AO) permeates all cells and makes the
nuclei to appear green. Ethidium bromide (EB) is only taken
up by cells when cytoplasmic membrane integrity is lost and
stains the nucleus in red. Thus, live cells have a normal green
nucleus, apoptotic cells have bright green nucleus with
condensed or fragmented chromatin; cells died from direct
necrosis have a structurally normal orange–red nucleus.
Floating cells were collected in a 15ml tube, adherent cells
were harvested by trypsinization and added to the same
15ml tube. Cells were centrifuged and resuspended in AO/
EB solution then dropped onto glass microscope slides.
Apoptotic cells were evaluated by using a Zeiss Axioskop
microscope with a 20 objective. At least 150 cells for each
sample were scored and the experiment was repeated twice.
Statistical analysis
All experiments were repeated at least twice and statistically
analyzed by the Student’s t Test. In the ﬁgures the symbol **
indicates a P value <0.01 and the symbol * indicates a P value
<0.05.
Results
Ectopic expression of p14ARF in MAD2
post-transcriptional silenced HCT116 cells induced
slowing down of proliferation
Previously, we showed that post-transcriptional silencing of
the MAD2 gene in primary human ﬁbroblast (IMR90),
mimicking MAD2 haploinsufﬁciency, induced aneuploidy
followed by the increase of p14ARF protein and premature
cellular senescence. On the contrary, MCF10A cells that
have the p14ARF deleted did not activate a senescence
pathway, though they became aneuploidy after MAD2
post-transcriptional silencing. These results suggested a role
for p14ARF in aneuploidy control (Lentini et al., 2012).
Accordingly, to understand if p14ARF is able to counteract
aneuploidy caused by MAD2 haploinsufﬁciency, we
Fig. 1. p14ARFectopic expression and MAD2 post-transcriptional silencing in HCT116 cells. A: Real Time RT-PCR analysis showing RNA
interference of siMAD2 #2, siMAD2 #1 and siMAD2-scramble at 72h after transfection. B: Western Blot analysis at 72 h post transfection
showing that RNA interference induced the reduction of MAD2 protein level in siMAD2 (2) and siMAD2/pcDNA3.1-p14 (4) HCT116 cells in
comparison toWT (1) and pcDNA3.1-p14 (3) HCT116 cells, below theWB panel is showed the densitometry analysis to quantitate the MAD2
protein as normalized to b-Tubulin. C: Western blot analysis confirmed p14ARF protein increase 72h after pcDNA3.1-p14 plasmid transient
transfection in HCT116 pcDNA3.1-p14 (1) and HCT116 siMAD2/pcDNA3.1-p14 (2) compared to HCT116 pcDNA3.1 (3) and HCT116 siMAD2
(4); the graph above shows p14ARF protein levels normalized to b-Tubulin.
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ectopically expressed p14ARF in HCT116 cells that have one
p14ARF allele deleted and the other allele is silenced by DNA
hypermethylation of the promoter (Burri et al., 2001).
HCT116 cells were chosen because they are an established
near-diploid cell line that maintains a stable karyotype
(Lengauer et al., 1997). In order to mimic MAD2
haploinsufﬁciency, we utilized the RNA interference strategy
by using two different small interfering RNA (siRNAs)
targeting the MAD2 transcript (siMAD2 #1, siMAD2 #2).
Real-time qRT-PCR analysis showed that the siMAD2 #1 was
able to reduce the amount of MAD2 transcript just about
50%. Thus, we decided to conduct all subsequent
experiments using the siMAD2#1 (Fig. 1A). Western blot
experiments conﬁrmed that RNA interference reduced to
about 50% the MAD2 protein in HCT116 transfected cells
(Fig. 1B).
To express ectopically p14ARF, HCT116 cells were
transfected with the plasmid pcDNA3.1 carrying the p14ARF
c-DNA (Ayrault et al., 2006). By Western blot analysis, the
p14ARF expression was conﬁrmed in all samples transfected
with the pcDNA3.1-p14 plasmid when compared to
HCT116-wt cells. Early effects of p14ARF ectopic expression
and MAD2 depletion were estimated by evaluating the
cellular density/dish 48 h and 72 h post-transfection. While
there were no statistically signiﬁcant differences in
proliferation between cells transfected with siMAD2 and
siMAD2-scramble siRNAs, ectopic expression of p14ARF
induced a decrease of cell number in MAD2 silenced cells, as
displayed by microscopic observation (Fig. 2A). This result
seems to be caused by p14ARF ectopic expression, since cells
transfected with control cells (siMAD2 scramble/
pcDNA3.1-p14 or siMAD2/pcDNA3.1) did not show
reduction in cell numbers at 72 h post transfection (Fig. 2 B
and C).
Ectopic expression of p14ARF reduced aneuploid cells and
mitotic abnormalities caused by MAD2 depletion
In agreement with previous reports (Thompson and Compton,
2010; Lentini et al., 2012) analysis of mitotic cells by
cytogenetics revealed the presence of more than 90% of
aneuploid cells after partial depletion of MAD2. The majority
(75%) of these mitotic cells were hypodiploid and only 16%
were hyperdiploid (Fig. 3A). Thus, weakening the SAC by
MAD2 depletion induced aneuploidy in near diploid HCT116
cells. Previously, it was suggested that p14ARF could play some
roles in aneuploidy (Barra et al., 2012; Silk et al., 2013). To get
additional clues on this aspect we estimated aneuploidy in
HCT116 cells depleted of MAD2 and with transient expression
of ectopic p14ARF. Both in siMAD2-scramble and in
pcDNA3.1-p14 HCT116 cells the aneuploidy level changed
slightly in comparison to control. As expected the number of
aneuploid cells dropped to 60% (56% hypodiploid and 4%
hyperdiploid) after transient expression of ectopic p14ARF in
MAD2-depleted HCT116 cells. On the contrary,
MAD2-depleted HCT116 cells and then transfected with the
pcDNA3.1-empty vector still showed a high percentage of
aneuploid cells (79%) similar to that shown by cells transfected
with siMAD2 alone (Fig. 3A).
Since aneuploidy may be associated with aberrant mitosis,
we then evaluated the presence of mitotic spindle alterations
after p14ARF ectopic expression and MAD2 depletion in
HCT116 cells. Detection of b-tubulin of cells in mitosis
Fig. 2. p14ARF ectopic expression reduces proliferation of MAD2-depleted HCT116 cells. A: Pictures showing the cell density/dish of siMAD2
and siMAD2/pcDNA3.1-p14 HCT116 cells at 0 and 72h. B: The graph shows HCT116 cell proliferation at 0, 48, and 72h after transfection of
siRNA targeting MAD2 transcript (siMAD2), scrambled-siMAD2, and pcDNA3.1, pcDNA3.1-p14. C: The graph shows cell proliferation of
siMAD2/pcDNA3.1, siMAD2/pcDNA3.1-p14, and siMAD2 scramble/pcDNA3.1-p14 HCT116 cells at 0, 48, and 72h post transfection. The
experiment was repeated twice. (Student’s t test * P< 0.05; ** P< 0.01, n¼ 50).
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Fig. 3. Aneuploidy and mitotic alteration are reduced in HCT116 siMAD2 cells following p14ARF ectopic expression. A: Representative
pictures of aneuploid metaphases (left) found in siMAD2, siMAD2/pcDNA3.1-p14 HCT116 cells and euploid metaphases of pcDNA3.1, and
siMAD2 scramble HCT116 cells (right). On the right the graph showing the percentages of aneuploid cells in HCT116 pcDNA3.1 (1) (Mitotic
Index (MI):15), siMAD2-scramble (2) (MI:14), pcDNA3.1-p14 (3) (MI:13), siMAD2-scramble/pcDNA3.1-p14 (4) (MI:13), siMAD2 (5) (MI:6),
siMAD2/pcDNA3.1 (6) (MI:11), and siMAD2/pcDNA3.1-p14 (7) (MI:9). B: On the right representative images of mitotic alterations detected
by b-tubulin staining in all samples analyzed (DNA was stained with DAPI); on the left the percentages of normal and altered metaphases in
pcDNA3.1 (1), siMAD2-scramble (2), pcDNA3.1-p14 (3), siMAD2-scramble/pcDNA-p14 (4), siMAD2 (5), siMAD2/pcDNA3.1 (6), and siMAD2/
pcDNA3.1-p14 (7) HCT116 cells. C: The graph summarizes the percentages of specific mitotic spindle alterations detected. All experiments
were repeated at least twice. (Student’s t test * P< 0.05; ** P< 0.01, n¼ 50 metaphases).
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revealed mitotic alterations as follows: monopolar spindles, all/
few chromosome outside of the spindle, and wrong orientation
of the spindle. These altered mitosis were especially found in
MAD2-depleted HCT116 cells (61%), and were reduced (40%)
when p14ARF was ectopically expressed (Fig. 3 B and C). These
results are similar to those reported by the Weaver group
where haploinsufﬁciency of CENPE, another player of the SAC,
induced mitotic spindle alterations (Silk et al., 2013).
The ﬁnding that the percentage of altered metaphases is
reduced in cells re-expressing p14ARF in comparison to
HCT116 siMAD2/pcDNA3.1, suggested that p14ARF
re-expression promotes the elimination of aneuploid cells
caused by MAD2 depletion (Fig. 3 B and C).
p14ARF ectopic expression induces apoptosis and not
premature cellular senescence in aneuploid cells
Previously, we showed that post-transcriptional silencing of
MAD2 and DNMT1 genes induced aneuploidy in human
primary ﬁbroblasts followed by premature cellular senescence,
mediated by p14ARF, as a possible way to block aneuploid cells
(Barra et al., 2012; Lentini et al., 2012). We investigated then
whether p14ARF could activate the senescence pathway after
MAD2 depletion in HCT116 cells. To this aim we conducted a
senescence-associated b-galactosidase (b-gal) activity assay to
evaluate the percentages of senescent cells after siMAD2 and
p14ARFectopic expression. This assay was carried out at two
different pH values: at pH6 only senescent cells were stained in
blue while at pH4, that we used as a control, both senescent
cells and proliferative cells were stained in blue. We found low
percentages of b-gal positive cells in all samples analyzed
(Fig. 4), suggesting that in MAD2-depleted HCT116 cells
ectopic expression of p14ARF does not activate a cellular
senescence pathway.
Following simultaneous p14ARF ectopic expression and
siMAD2 post-transcriptional silencing, we found the
presence of many ﬂoating cells (data not shown). To assess if
apoptosis was responsible for these dead cells, we conducted
the Acridine Orange/Ethidium Bromide (AO/EB) assay that
distinguishes live cells from both apoptotic and necrotic cells
(Fig. 5A). We found a high percentage of apoptotic (36%) and
necrotic cells (17%) following p14ARF ectopic expression and
MAD2 depletion. By applying the Student’s t test, these
percentages of apoptotic and necrotic cells were statistically
signiﬁcant in comparison to the percentages found in
siMAD2/pcDNA3.1 (22% apoptotic and 6% necrotic) and
siMAD2-scramble/pcDNA3.1 (16% apoptotic and 3%
necrotic) samples. In contrast, a small percentage of
apoptotic cells (11% and 17%) detected in HCT116
MAD2-depleted cells and in siMAD2 scramble/
pcDNA3.1-p14 cells, respectively, was not statistically
signiﬁcant by the Student’s t test (Fig. 5B). The similarity
between the percentage of apoptotic cells and the reduction
of aneuploid cells after p14ARFectopic expression suggest
apoptosis as a major mechanism to eliminate aneuploid cells
(Fig. 5B). Since the p14ARF gene can act in p53-dependent and
p53-independent apoptotic pathways activated following
DNA damage (Ozenne et al., 2010), we investigated whether
p14ARF cooperated with p53 activating apoptosis in response
to aneuploidy. To this aim, we conducted a Western Blot
analysis to evaluate the p53 protein levels. MAD2
post-transcriptional silencing and p14ARF ectopic expression
induced a signiﬁcant increase of p53 protein levels compared
to control. These ﬁndings suggest a possible collaboration
between p14ARF and p53 to counteract aneuploidy (Fig. 5C).
To clarify the role of p53 in the induction of apoptosis after
p14ARF ectopic expression in aneuploid cells, we used
HCT116 p53KO cells transfected with siMAD2 and
pcDNA3.1-p14. The AO/EB assay in HCT116 p53KO cell,
following p14ARF ectopic expression showed that the
percentage of apoptotic cells (20%) found in HCT116
siMAD2/pcDNA3.1-p14 cells was comparable with the
percentage found in cells transfected with siMAD2 and the
pcDNA3.1 empty vector (18%). Following MAD2
post-transcriptional silencing and p14ARF ectopic expression,
we detected the decrease of apoptotic cells in the absence of
the p53 gene. This result suggests that cells were eliminated
through a p53-dependent apoptotic pathway where p14ARF
had a key role (Fig. 6 A)
In agreement with this result cytogenetic analyses showed
that siMAD2 induced higher number of aneuploid cells in
HCT116 p53KO cells (61%) than siMAD2-scramble cells
(21%). On the contrary, HCT116 p53KO cells that expressed
p14ARF ectopically showed a percentage of aneuploid cells
(66%) similar to the percentage showed by HCT116 p53KO
siMAD2/pcDNA3.1 cells (77%) and HCT116-siMAD2 cells
(61%). These differences were not statistical signiﬁcant by the
Student’s t test. Thus, in the absence of p53 activity p14ARF did
not induce the elimination of aneuploid cells caused by MAD2
depletion (Fig. 6B). Real Time qRT-PCR analyses conﬁrmed
Fig. 4. p14ARF does not induce cellular senescence in MAD2-depleted cells. On the left representative pictures of pcDNA3.1, siMAD2, and/or
pcDNA3.1-p14 HCT116 cells, 72 h after transfection stained for b-gal (pH4: young and senescent cells, pH6: senescent cells). On the right the
graph summarizes the percentage of senescent HCT116 cells (b-gal positive): pcDNA3.1 (1), siMAD2 (2), pcDNA3.1-p14 (3), and siMAD2/
pcDNA3.1-p14 (4) The differences are not statistical significant.
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Fig. 5. p14ARF ectopic expression induces apoptosis and increase of p53 protein levels in MAD2-depleted HCT116 cells. A: Examples of
HCT116 cells stained with Orange Acridine and Ethidium Bromide 72h after transfection; the orange arrow (merge panel, bottom left) points
to live cells, yellow (white) and blue (gray) arrows points to necrotic and apoptotic cells (merge panel, bottom right), respectively. B: The
graph summarizes the percentage of live, apoptoti,c and necrotic HCT116 cells transfected with pcDNA3.1 (1), pcDNA3.1-p14 (2), siMAD2
(3), siMAD2-scramble (4), siMAD2/pcDNA3.1 (5), siMAD2-scramble/pcDNA3.1-p14 (6), siMAD2/pcDNA3.1-p14 (7), and siMAD2-scramble/
pcDNA3.1 (8). The experiment was repeated at least twice. (Student’s t test * P< 0.05; ** P< 0.01, n¼ 150). C: Western blot analysis showing
the increase of p53 protein levels after p14ARF ectopic expression, in HCT116 pcDNA3.1-p14 (2), HCT116 siMAD2 (3), and in HCT116
siMAD2/pcDNA3.1-p14 (4) cells when compared to HCT116 control cells (1); on the right is showed the densitometric analysis of the WB on
the left panel to quantitate the p53 protein level that is normalized to b-Tubulin.
JOURNAL OF CELLULAR PHYSIOLOGY
342 V E N E Z I A N O E T A L .
that siMAD2#1 induced MAD2 gene post-transcriptional
silencing of about 50% compared to siMAD2-scramble and
p53KO HCT116 cells (Fig. 6C)
Discussion
During mitosis the proper chromosomes segregation is
controlled by a speciﬁc checkpoint, the Spindle Assembly
Checkpoint (SAC). If any of SAC components is mutated or its
expression is reduced, miss-segregation events would not be
correctly reported, promoting aneuploidy development (Silva
et al., 2011). The p14ARF protein plays several biological
functions in the cell with the purpose to suppress aberrant cell
growth. The well-deﬁned function of p14ARF is to stabilize and
activate p53 by neutralizing the inhibitory effects of the E3
ubiquitin ligase hMdm2 in response to oncogenic stress
(hyperproliferative signals) (Sharpless, 2005). Though the
p14ARF protein is a key player in this p53 pathway, there are
evidences that it could promote a p53-independent cell cycle
arrest and/or apoptosis (Weber et al., 2000; Muer et al., 2012).
p14ARF expression is generally lost by deletion or
hypermethylation of CpG islands localized at its promoter
region (Badal et al., 2008). Hypermethylation of p14ARF
promoter has been reported in many tumors, and this loss
occurs at early stages of tumorigenesis in some tumors such as
colorectal, gastric, prostate, and breast cancer (Ozenne et al.,
2010). In many human cancers, deregulation of the p53 pathway
usually occurs by inactivation of the TP53 gene through point
mutations. Moreover, inactivation of the p14ARF gene has been
proposed as a mechanism that disrupt p53 activity in tumors
with wild-type TP53 gene (Nyiraneza et al., 2012).
In agreement with our previous data (Amato et al., 2009),
weakening the SAC by MAD2 post-transcritional silencing
increased aneuploidy in HCT116 cells. However, when we
restored p14ARF functionality by ectopic gene expression in
these aneuploid cells aneuploidy, cell proliferation was
reduced. At the same time, mitotic abnormality observed after
MAD2 post-transcriptional silencing decreased as a result of
Fig. 6. p14ARF does not induce apoptosis in HCT116 p53KO cells. A: On the left are showed representative pictures of the indicated cells
stained with Orange Acridine and Ethidium Bromide solution, 72 h after transfection; the graph on the right summarizes the percentages of
live, apoptotic, and necrotic cells in pcDNA3.1 (1), pcDNA3.1-p14 (2), siMAD2 (3), siMAD2/pcDNA3.1 (4), and siMAD2/pcDNA3.1-p14 (5)
-HCT116 cells. B: The graph shows the percentages of aneuploid cells in p53 KO pcDNA3.1 (1), pcDNA3.1-p14 (2), siMAD2-scramble (3),
siMAD2 (4), siMAD2/pcDNA3.1 (5), siMAD2/pcDNA3.1-p14 (6), and HCT116 cells. All experiments were repeated at least twice. (Student’s t
test * P< 0.05; ** P< 0.01, n¼ 150). C: Real time RT-PCR analysis showing RNA interference of siMAD2#1 and siMAD2 scramble in HCT116
p53KO cells at 72 h after transfection.
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p14ARF ectopic expression. These ﬁndings suggest that p14ARF
is able to prevent proliferation of aneuploid cells caused by
reduction of SAC activity.
Recently, we showed (Lentini et al., 2012) that after
induction of aneuploidy by MAD2 post-transcriptional
silencing, human primary ﬁbroblast activated a premature
cellular senescence response p53-mediated to halt aneuploid
cells proliferation. By contrast, our results show that
premature cellular senescencewas not activated in response to
aneuploidy in HCT116 tumor cells where p14ARF was
ectopically expressed. The presence of apoptotic cells in
MAD2-depleted HCT116 tumor cells in response to p14ARF
ectopic expression, suggest induction of apoptosis as the
mechanism adopted by p14ARF to counteract aneuploid cells
proliferation. Apoptosis was associated with the increase of
p53 protein, suggesting that re-expression of p14ARF in these
aneuploid cells induces a p53-dependent apoptosis. The
existence of a p14ARF-p53 axis is conﬁrmed by experiments
done in HCT116 p53KO cells, where cells interfered for
MAD2 become aneuploidy but did not show increased number
of apoptotic cells when p14ARF was re-expressed.
Previously, itwas suggested that a p38kinase–dependent stress
response activates p53 to induce the p21waf1 in response to
chromosome mis-segregation in HCT116 cells (Thompson and
Compton, 2010). Likely, the cellular signal triggering this pathway
relies on the presence of DNA damage that could be caused by
chromosomal mechanical stress. On the contrary, our results
suggest that, after p14ARF re-expression, apoptosis activation
p53-dependent hampers aneuploid cell proliferation. Most likely,
this mechanism could signal the presence of gene expression
imbalance resulting from chromosomemis-segregation (Williams
et al., 2008).Generally, geneexpression correlateswith genecopy
number and aneuploidy, then unbalancing genomic material could
induce a signal resembling hyperproliferative signals that are
typically sensed by p14ARF.
Finally, our ﬁndings reinforce the idea that the abolition of
p14ARF expression or p14ARF related partners that control
genomic stability is one of the strategies adopted by human
tumor cells to tolerate aneuploidy.
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